IDRx’s lead candidate IDRX-42 is being investigated in a Phase I/IIb trial in patients with advanced gastrointestinal stromal ...

Fintel reports that on January 17, 2025, JP Morgan downgraded their outlook for Lucky Strike Entertainment (NYSE:LUCK) from ...

We’ll hear from speakers representing Syneos Health, Flagship Pioneering, and IPSEN on pharma dealmakers’ 2025 intentions, ...

It’s been a busy week for Illumina at the JP Morgan 2025 Healthcare conference, with the company revealing partnerships and ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

New Delhi, January 16 (ANI): "Families using LPG will get a Rs 500 subsidy per cylinder, and on Holi and Diwali, they will ...

After Donald Trump becomes president again on Monday, he is on the hook for achieving a hefty chunk of his promises even ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...

Asia Market Update: JP tech pares gains seen following TSMC Capex guidance; China achieves 2024 GDP target; Quieter day for ...

Bhopal (Madhya Pradesh): A state-of-the-art 1.5 Tesla MRI machine has been installed at JP District Hospital, offering a ...

Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...